Regeneron Pharmaceuticals, Inc. (REGN)
793.33
-14.38
(-1.78%)
USD |
NASDAQ |
Aug 28, 11:46
Regeneron Pharmaceuticals 30-Day Average Daily Volume : 778928.9 for Aug. 27, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 27, 2026 | 778928.9 |
| August 26, 2026 | 777704.1 |
| August 25, 2026 | 776705.8 |
| August 24, 2026 | 775791.3 |
| August 21, 2026 | 773601.0 |
| August 20, 2026 | 766762.9 |
| August 19, 2026 | 769298.0 |
| August 18, 2026 | 769177.6 |
| August 17, 2026 | 773839.7 |
| August 14, 2026 | 779607.5 |
| August 13, 2026 | 801140.9 |
| August 12, 2026 | 816504.6 |
| August 11, 2026 | 824696.6 |
| August 10, 2026 | 817874.6 |
| August 07, 2026 | 817869.1 |
| August 06, 2026 | 813177.9 |
| August 05, 2026 | 815044.0 |
| August 04, 2026 | 839956.9 |
| August 03, 2026 | 866190.8 |
| July 31, 2026 | 925075.1 |
| July 30, 2026 | 929778.7 |
| July 29, 2026 | 914662.0 |
| July 28, 2026 | 907777.3 |
| July 27, 2026 | 901689.7 |
| July 24, 2026 | 911429.3 |
| Date | Value |
|---|---|
| July 23, 2026 | 915019.9 |
| July 22, 2026 | 917061.5 |
| July 21, 2026 | 929963.6 |
| July 20, 2026 | 944830.6 |
| July 17, 2026 | 956495.7 |
| July 16, 2026 | 967771.9 |
| July 15, 2026 | 978997.3 |
| July 14, 2026 | 996493.6 |
| July 13, 2026 | 1.053M |
| July 10, 2026 | 1.074M |
| July 09, 2026 | 1.119M |
| July 08, 2026 | 1.126M |
| July 07, 2026 | 1.134M |
| July 06, 2026 | 1.143M |
| July 02, 2026 | 1.158M |
| July 01, 2026 | 1.170M |
| June 30, 2026 | 1.231M |
| June 29, 2026 | 1.228M |
| June 26, 2026 | 1.229M |
| June 25, 2026 | 1.218M |
| June 24, 2026 | 1.222M |
| June 23, 2026 | 1.235M |
| June 22, 2026 | 1.212M |
| June 18, 2026 | 1.185M |
| June 17, 2026 | 1.122M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.034M |
| Gilead Sciences, Inc. | 6.391M |
| AbbVie, Inc. | 5.130M |
| Vertex Pharmaceuticals, Inc. | 1.258M |
| Amgen, Inc. | 2.623M |